Eric Bjerkholt - Sep 11, 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Sep 11, 2024
Transactions value $
$0
Form type
4
Date filed
9/12/2024, 04:18 PM
Previous filing
Aug 28, 2024
Next filing
Nov 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Options Exercise +18.3K +126.7% 32.8K Sep 11, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Restricted Stock Units Options Exercise $0 -18.3K -33.33% $0.00 36.7K Sep 11, 2024 Common Stock 18.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
F2 The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023.